Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa.
Korte EWH, Pasmooij AMG, Bolling MC, Hickey S, Hussain S, Kiritsi D, Kottner J, Prinsen CAC, Sauvestre A, Sendin G, Spuls PI, Tarrats N, Wally V, Welponer T, Laimer M, van den Akker PC; COSEB Consortium. Korte EWH, et al. Among authors: kiritsi d. Br J Dermatol. 2024 Aug 14;191(3):463-465. doi: 10.1093/bjd/ljae200. Br J Dermatol. 2024. PMID: 38865426 No abstract available.
Molecular therapies for epidermolysis bullosa.
Has C, Kiritsi D. Has C, et al. Among authors: kiritsi d. G Ital Dermatol Venereol. 2013 Feb;148(1):65-72. G Ital Dermatol Venereol. 2013. PMID: 23407078 Review.
Therapies for inherited skin fragility disorders.
Has C, Kiritsi D. Has C, et al. Among authors: kiritsi d. Exp Dermatol. 2015 May;24(5):325-31. doi: 10.1111/exd.12666. Exp Dermatol. 2015. PMID: 25916580 Review.
Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort.
Kern JS, Grüninger G, Imsak R, Müller ML, Schumann H, Kiritsi D, Emmert S, Borozdin W, Kohlhase J, Bruckner-Tuderman L, Has C. Kern JS, et al. Among authors: kiritsi d. Br J Dermatol. 2009 Nov;161(5):1089-97. doi: 10.1111/j.1365-2133.2009.09333.x. Epub 2009 Jun 5. Br J Dermatol. 2009. PMID: 19681861
Laminin 332 in junctional epidermolysis bullosa.
Kiritsi D, Has C, Bruckner-Tuderman L. Kiritsi D, et al. Cell Adh Migr. 2013 Jan-Feb;7(1):135-41. doi: 10.4161/cam.22418. Epub 2012 Oct 17. Cell Adh Migr. 2013. PMID: 23076207 Free PMC article. Review.
Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa.
Kiritsi D, Garcia M, Brander R, Has C, Meijer R, Jose Escámez M, Kohlhase J, van den Akker PC, Scheffer H, Jonkman MF, Del Rio M, Bruckner-Tuderman L, Pasmooij AMG. Kiritsi D, et al. J Invest Dermatol. 2014 Aug;134(8):2097-2104. doi: 10.1038/jid.2014.118. Epub 2014 Feb 27. J Invest Dermatol. 2014. PMID: 24577406 Free article.
117 results